ID: ALA284952

Max Phase: Preclinical

Molecular Formula: C18H16N2O2

Molecular Weight: 292.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(-c2nc(C3OCCO3)[nH]c2-c2ccccc2)cc1

Standard InChI:  InChI=1S/C18H16N2O2/c1-3-7-13(8-4-1)15-16(14-9-5-2-6-10-14)20-17(19-15)18-21-11-12-22-18/h1-10,18H,11-12H2,(H,19,20)

Standard InChI Key:  LQICXRNBJXHQRX-UHFFFAOYSA-N

Associated Targets(non-human)

Acyl coenzyme A:cholesterol acyltransferase 1 2344 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.34Molecular Weight (Monoisotopic): 292.1212AlogP: 3.79#Rotatable Bonds: 3
Polar Surface Area: 47.14Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.96CX Basic pKa: 3.85CX LogP: 3.59CX LogD: 3.59
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.80Np Likeness Score: -0.49

References

1. Astles PC, Ashton MJ, Bridge AW, Harris NV, Hart TW, Parrott DP, Porter B, Riddell D, Smith C, Williams RJ..  (1996)  Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.,  39  (7): [PMID:8691472] [10.1021/jm9505876]
2. Wu YJ, Meanwell NA..  (2021)  Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design.,  64  (14.0): [PMID:34213340] [10.1021/acs.jmedchem.1c00790]

Source